The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
It's been said. Lots of need with aging boomers and Type2 Diabetes (with resultant renal failure) rising. Small risk that payments may get sqeezed in the future. And safe if the bears take hold. I've actually owned it for a few years in one of my retirement portfolios and it continues to do well. (I like to have stocks that I can leave for decades untouched in there.)